N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine—A Review
Pediatric oncology is a critical area where the more efficient development of new treatments is urgently needed. The speed of approval of new drugs is still limited by regulatory requirements and a lack of innovative designs appropriate for trials in children. Childhood cancers meet the criteria of...
Saved in:
Main Authors: | Michal Kyr, Adam Svobodnik, Radka Stepanova, Renata Hejnova |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e362beda12c3412aac9b32d23e3902c8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Cost of Oncology Medicines
by: Zlatareva A., et al.
Published: (2017) -
Pediatric Oncology Palliative Care Programs in Central America: Pathways to Success
by: Wendy Cristhyna Gómez García, et al.
Published: (2021) - Clinical medicine reviews in oncology
-
Precision oncology- the future of personalized cancer medicine?
by: Ann M. Bode, et al.
Published: (2017) - European Journal of Oncological Medicine